Market Overview

OvaScience to Launch New Potential Fertility Treatment OvaPrime in 2015


OvaScienceSM, (NASDAQ: OVAS) today provided an update on its product pipeline and
commercial plans, which are based on its egg precursor cell (EggPCSM)
technology platform. OvaScience expects to commercialize AUGMENTSM
in international in vitro fertilization (IVF) clinics in 2014 and
to launch its newest potential fertility treatment, OvaPrimeSM,
in 2015.

See full press release

Posted-In: News Guidance Management Global


Related Articles (OVAS)

View Comments and Join the Discussion!

Partner Center